MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Century Therapeutics, Inc. Common Stock

IPSC

#3009
Century Therapeutics, Inc. Common Stock
2.32
+6.42%
Sector:
Base:
Profit Currency:
Daily Range
2.32
2.32
Year Range
0.34
2.71
Daily Change
+6.42%
Monthly Change
-13.43%
6 month change
+346.15%
Year Change
+256.92%
Previous Close
2.18
Open
2.32
Bid
Ask
Low
2.32
High
2.32
Volume
15
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. IPSC
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

News

Investing Investing
IPSC
2026.02.25
TD Cowen initiates Century Therapeutics stock rating at Buy
Investing Investing
MSFT ORCL MRK AMGN NVDA
2026.02.09
Oracle, Palantir among market cap stock movers on Monday
Zacks Zacks
IPSC
2026.01.22
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know
Investing Investing
IPSC
2026.01.20
Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler
Investing Investing
IPSC
2026.01.08
Century Therapeutics stock price target lowered to $6.60 at Clear Street
Investing Investing
IPSC
2026.01.08
Century Therapeutics secures $135 million in private placement
Zacks Zacks
ALKS CRMD IPSC INDV
2026.01.07
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug
Zacks Zacks
IPSC
2026.01.07
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
Zacks Zacks
IPSC
2025.12.09
Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors
Investing Investing
IPSC
2025.12.09
Century Therapeutics appoints two new board members
Investing Investing
IPSC
2025.11.17
Century Therapeutics stock downgraded by Leerink Partners on lack of catalysts
Investing Investing
IPSC
2025.11.13
Century Therapeutics unveils T1D therapy program with immune evasion tech

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd